Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer

References

• Cancer Genome Atlas Research N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337.
   Google Scholar
• Duchaine TF, Fabian MR. Mechanistic insights into MicroRNA-mediated gene silencing. Cold Spring Harb Perspect Biol. 2019;11.
   Google Scholar
• Michael MZ, SM OC, Van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003;1:882–891.
   Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866.
   Google Scholar
• Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009;8:102.
   Google Scholar
• Slattery ML, Herrick JS, Pellatt DF, et al. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis. 2016;37:245–261.
   Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–269.
   Google Scholar
• Zhu H, Dougherty U, Robinson V, et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res. 2011;9:960–975.
   Google Scholar
• Nedaeinia R, Sharifi M, Avan A, et al. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Tumour Biol. 2017;39:1010428317692261.
   Google Scholar
• Mustafi R, Dougherty U, Mustafi D, et al. ADAM17 is a tumor promoter and therapeutic target in Western diet-associated colon cancer. Clin Cancer Res. 2017;23:549–561.
   Google Scholar
• Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.
   Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4.
   Google Scholar
• Johannessen C, Moi L, Kiselev Y, et al. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. PLoS One. 2017;12:e0186658.
   Google Scholar
• Zaman MS, Chen Y, Deng G, et al. The functional significance of microRNA-145 in prostate cancer. Br J Cancer. 2010;103:256–264.
   Google Scholar
• Borralho PM, Simoes AE, Gomes SE, et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One. 2011;6:e23787.
   Google Scholar
• Ibrahim AF, Weirauch U, Thomas M, et al. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res. 2011;71:5214–5224.
   Google Scholar
• Dougherty U, Cerasi D, Taylor I, et al. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2. Clin Cancer Res. 2009;15:6780–6789.
   Google Scholar
• Wu J, Yin L, Jiang N, et al. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells. Exp Cell Res. 2015;338:232–238.
   Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
   Google Scholar
• Dougherty U, Mustafi R, Haider HI, et al. Losartan and vitamin D inhibit colonic tumor development in a conditional Apc-deleted mouse model of sporadic colon cancer. Cancer Prev Res (Phila). 2019;12:433–448.
   Google Scholar
• Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–249.
   Google Scholar
• Untergasser A, Cutcutache I, Koressaar T, et al. Primer3 – new capabilities and interfaces. Nucleic Acids Res. 2012;40:e115.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2exp(-ΔΔ CT) Method. Methods. 2001;25:402–408.
   Google Scholar
• Yuan JS, Reed A, Chen F, et al. Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006;7:85–97.
   Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–682.
   Google Scholar
• Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357.
   Google Scholar
• Ghasemi A, Zahediasl S. Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2012;10:486–489.
   Google Scholar
• Rossi S, Di Narzo AF, Mestdagh P, et al. microRNAs in colon cancer: a roadmap for discovery. FEBS Lett. 2012;586:3000–3007.
   Google Scholar
• Doberstein K, Steinmeyer N, Hartmetz AK, et al. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia. 2013;15:218–230.
   Google Scholar
• Liu Y, Wu C, Wang Y, et al. MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma. Oncol Rep. 2014;32:1923–1930.
   Google Scholar
• Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature. 2008;455:64–71.
   Google Scholar
• Chan LY, Mugler CF, Heinrich S, et al. Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability. Elife. 2018;7.
   Google Scholar
• Blanchot-Jossic F, Jarry A, Masson D, et al. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells. J Pathol. 2005;207:156–163.
   Google Scholar
• Faber C, Horst D, Hlubek F, et al. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer. 2011;47:1414–1419.
   Google Scholar
• Chivukula RR, Shi G, Acharya A, et al. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 2014;157:1104–1116.
   Google Scholar
• De Robertis M, Massi E, Poeta ML, et al. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9.
   Google Scholar
• Wang Z. The guideline of the design and validation of miRNA mimics. Methods Mol Biol. 2011;676:211–223.
   Google Scholar
• Bauer KM, Hummon AB. Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome. J Proteome Res. 2012;11:4744–4754.
   Google Scholar
• Pagliuca A, Valvo C, Fabrizi E, et al. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013;32:4806–4813.
   Google Scholar
• Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009;28:1385–1392.
   Google Scholar
• Satoh K, Yachida S, Sugimoto M, et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci U S A. 2017;114:E7697–E706.
   Google Scholar
• Giardina C, Nakanishi M, Khan A, et al. Regulation of VDR expression in Apc-mutant mice, human colon cancers and adenomas. Cancer Prev Res (Phila). 2015;8:387–399.
   Google Scholar
• Kaiser S, Park YK, Franklin JL, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007;8:R131.
   Google Scholar
• Shigeyasu K, Okugawa Y, Toden S, et al. Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer. Clin Cancer Res. 2017;23:1312–1322.
   Google Scholar
• Cristobal I, Torrejon B, Rubio J, et al. Deregulation of SET is associated with tumor progression and predicts adverse outcome in patients with early-stage colorectal cancer. J Clin Med. 2019;8.
   Google Scholar
• Cristobal I, Rincon R, Manso R, et al. Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer. Clin Cancer Res. 2015;21:347–356.
   Google Scholar
• Lu Y, Chopp M, Zheng X, et al. MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep. 2013;29:67–72.
   Google Scholar
• Liu Y, Wu C, Wang Y, et al. Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai). 2014;46:720–722.
   Google Scholar
• Su Y, Wang Y, Zhou H, et al. MicroRNA-152 targets ADAM17 to suppress NSCLC progression. FEBS Lett. 2014;588:1983–1988.
   Google Scholar
• Wu Y, Huang A, Li T, et al. MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17. FEBS Lett. 2014;588:2063–2069.
   Google Scholar
• Su Y, Wang Y, Zhou H, et al. MicroRNA-152 targets ADAM17 to suppress NSCLC progression. FEBS Lett. 2014;588:1983–1988.
   Google Scholar
• Vila-Casadesus M, Vila-Navarro E, Raimondi G, et al. Deciphering microRNA targets in pancreatic cancer using miRComb R package. Oncotarget. 2018;9:6499–6517.
   Google Scholar
• Kent OA, McCall MN, Cornish TC, et al. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res. 2014;42:7528–7538.
   Google Scholar
• Chen JT, Yao KH, Hua L, et al. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17. Int J Clin Exp Pathol. 2015;8:10922–10928.
   Google Scholar
• Li B, Xie Z, Li B. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3. Tumour Biol. 2016;37:10075–10084.
   Google Scholar
• Cao H, Liu Z, Wang R, et al. miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2. Oncol Rep. 2017;37:147–154.
   Google Scholar
• Zhu Y, Gu L, Li Y, et al. miR-148a inhibits colitis and colitis-associated tumorigenesis in mice. Cell Death Differ. 2017;24:2199–2209.
   Google Scholar
• Bhome R, Goh RW, Bullock MD, et al. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. Aging (Albany NY). 2017;9:2666–2694.
   Google Scholar
• Donnarumma E, Fiore D, Nappa M, et al. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget. 2017;8:19592–19608.
   Google Scholar
• Savardashtaki A, Shabaninejad Z, Movahedpour A, et al. miRNAs derived from cancer-associated fibroblasts in colorectal cancer. Epigenomics. 2019;11:1627–1645.
   Google Scholar
• Isella C, Terrasi A, Bellomo SE, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47:312–319.
   Google Scholar
• Pleiman JK, Irving AA, Wang Z, et al. The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer. PLoS Genet. 2018;14:e1007611.
   Google Scholar
• Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem. 1996;271:11059–11062.
   Google Scholar
• Rangrez AY, Massy ZA, Metzinger-Le Meuth V, et al. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet. 2011;4:197–205.
   Google Scholar
• Natera-Naranjo O, Aschrafi A, Gioio AE, et al. Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons. RNA. 2010;16:1516–1529.
   Google Scholar
• Chawla G, Sokol NS. ADAR mediates differential expression of polycistronic microRNAs. Nucleic Acids Res. 2014;42:5245–5255.
   Google Scholar
• Heo I, Joo C, Kim YK, et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell. 2009;138:696–708.
   Google Scholar
• Heo I, Joo C, Cho J, et al. Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol Cell. 2008;32:276–284.
   Google Scholar
• Vizcaino JA, Csordas A, del-Toro N, et al. Update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44:D447–56.
   Google Scholar
• Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A. 2012;109:3347–3352.
   Google Scholar
• Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24:R762–76.
   Google Scholar
• Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg. 2010;14:1170–1179.
   Google Scholar
• Gaedcke J, Grade M, Camps J, et al. The rectal cancer microRNAome–microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res. 2012;18:4919–4930.
   Google Scholar
• Slattery ML, Herrick JS, Mullany LE, et al. Diet and lifestyle factors associated with miRNA expression in colorectal tissue. Pharmgenomics Pers Med. 2017;10:1–16.
   Google Scholar
• Nara T, Narita S, Mingguo H, et al. Altered miRNA expression in high-fat diet-induced prostate cancer progression. Carcinogenesis. 2016;37:1129–1137.
   Google Scholar
• Melo S, Villanueva A, Moutinho C, et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011;108:4394–4399.
   Google Scholar